Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP59133.RASkUEKdDhcOPtDj-CRuD_6ig9DdH2TBvt8s9x5lxK_3I130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP59133.RASkUEKdDhcOPtDj-CRuD_6ig9DdH2TBvt8s9x5lxK_3I130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP59133.RASkUEKdDhcOPtDj-CRuD_6ig9DdH2TBvt8s9x5lxK_3I130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP59133.RASkUEKdDhcOPtDj-CRuD_6ig9DdH2TBvt8s9x5lxK_3I130_provenance.
- NP59133.RASkUEKdDhcOPtDj-CRuD_6ig9DdH2TBvt8s9x5lxK_3I130_assertion description "[Po-husk, apart from lowering LDL-C, also reduced TG, TG related to certain gene variants, TC, Apo B-100, oxLDL, insulin-resistance and systolic BP in mild-moderate hypercholesterolaemic individuals. Thus, the target patients to receive Po-husk would be th]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP59133.RASkUEKdDhcOPtDj-CRuD_6ig9DdH2TBvt8s9x5lxK_3I130_provenance.
- NP59133.RASkUEKdDhcOPtDj-CRuD_6ig9DdH2TBvt8s9x5lxK_3I130_assertion evidence source_evidence_literature NP59133.RASkUEKdDhcOPtDj-CRuD_6ig9DdH2TBvt8s9x5lxK_3I130_provenance.
- NP59133.RASkUEKdDhcOPtDj-CRuD_6ig9DdH2TBvt8s9x5lxK_3I130_assertion SIO_000772 20413122 NP59133.RASkUEKdDhcOPtDj-CRuD_6ig9DdH2TBvt8s9x5lxK_3I130_provenance.
- NP59133.RASkUEKdDhcOPtDj-CRuD_6ig9DdH2TBvt8s9x5lxK_3I130_assertion wasDerivedFrom gad-20150221 NP59133.RASkUEKdDhcOPtDj-CRuD_6ig9DdH2TBvt8s9x5lxK_3I130_provenance.
- NP59133.RASkUEKdDhcOPtDj-CRuD_6ig9DdH2TBvt8s9x5lxK_3I130_assertion wasGeneratedBy ECO_0000203 NP59133.RASkUEKdDhcOPtDj-CRuD_6ig9DdH2TBvt8s9x5lxK_3I130_provenance.
- gad-20150221 importedOn "2015-02-21" NP59133.RASkUEKdDhcOPtDj-CRuD_6ig9DdH2TBvt8s9x5lxK_3I130_provenance.